Copyright
©The Author(s) 2024.
World J Orthop. Dec 18, 2024; 15(12): 1155-1163
Published online Dec 18, 2024. doi: 10.5312/wjo.v15.i12.1155
Published online Dec 18, 2024. doi: 10.5312/wjo.v15.i12.1155
Table 4 Multivariate analysis of overall survival in patients with bone metastasis of gene mutation-negative non-small cell lung cancer
Characteristic | HR | 95%CI | P value | |
Use of ICIs after bone metastasis diagnosis | Yes | 0.35 | 0.14–0.86 | 0.023 |
Use of bone-modifying agent after bone metastasis diagnosis | Yes | 0.43 | 0.16–1.2 | 0.12 |
ECOG PS | ≤ 1 | 0.5 | 0.20–1.3 | 0.14 |
- Citation: Ishibashi Y, Kobayashi H, Ando T, Okajima K, Oki T, Tsuda Y, Shinoda Y, Sawada R, Tanaka S. Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective study. World J Orthop 2024; 15(12): 1155-1163
- URL: https://www.wjgnet.com/2218-5836/full/v15/i12/1155.htm
- DOI: https://dx.doi.org/10.5312/wjo.v15.i12.1155